stockrow
Friday 6 November 2026
Export VEEV’s income statement to Excel — free account
Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
- Revenue
- +17.6%
- EPS
- +36.6%
- Free cash flow
- −0.62%
Quarter to July 2026, against a year earlier
303.26
6.84
−2.21%
Follow VEEV
Alert me
| Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 | Jan '21 | Jan '20 | Jan '19 | Jan '18 | Jan '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
36.57 | 52.89 | 63.23 | 54.49 | 84.78 | 112.27 | 71.87 | 68.59 | 62.24 | 73.89 |
Piotroski F-Score |
7 | 7 | 5 | 5 | 6 | 5 | 5 | 7 | 7 | 8 |
Altman Z-Score |
13.57 | 17.18 | 17.84 | 16.76 | 26.31 | 34.16 | 23.43 | 24.93 | 18.45 | 14.99 |
P/S ratio |
10.42 | 13.75 | 14.09 | 12.30 | 19.59 | 29.09 | 19.63 | 18.25 | 12.77 | 10.43 |
Altman Z″-Score (non-manufacturers) |
11.21 | 10.62 | 10.10 | 9.78 | 9.64 | 8.71 | 7.88 | 9.35 | 8.60 | 7.56 |
P/FCF ratio |
24.01 | 35.31 | 37.62 | 34.55 | 48.32 | 78.56 | 50.04 | 52.26 | 39.72 | 42.08 |
P/Operating CF |
311.49 | 542.96 | 576.36 | 418.02 | 670.63 | 623.62 | 554.05 | 493.56 | 6,137.75 | (2,751.00) |
Beneish M-Score |
(2.63) | (2.59) | (2.63) | (2.64) | (2.83) | (2.47) | (1.69) | (2.51) | (2.59) | (2.75) |
P/B ratio |
4.61 | 6.47 | 7.17 | 7.13 | 12.45 | 18.81 | 13.01 | 12.71 | 9.73 | 8.80 |
Price to Tangible BV |
4.93 | 7.06 | 8.04 | 8.30 | 15.30 | 24.84 | 19.83 | 14.08 | 11.32 | 11.10 |
EV/Sales |
8.36 | 11.87 | 12.38 | 10.86 | 18.30 | 27.96 | 18.64 | 16.98 | 11.67 | 9.49 |
EV/EBITDA |
27.80 | 45.17 | 64.52 | 46.18 | 59.93 | 95.02 | 63.66 | 57.90 | 42.36 | 34.71 |
EV/Operating CF |
18.88 | 29.92 | 32.12 | 29.98 | 44.31 | 74.31 | 47.06 | 47.10 | 34.52 | 36.28 |
EV/FCF |
19.28 | 30.49 | 33.07 | 30.51 | 45.15 | 75.50 | 47.53 | 48.64 | 36.29 | 38.28 |
Quick Ratio |
4.81 | 4.44 | 4.17 | 3.86 | 3.65 | 3.18 | 2.74 | 3.52 | 3.27 | 2.84 |
Current Ratio |
4.89 | 4.51 | 4.24 | 3.94 | 3.70 | 3.23 | 2.78 | 3.57 | 3.31 | 2.88 |
Net Debt/EBITDA |
(6.83) | (7.13) | (8.88) | (6.12) | (4.20) | (3.86) | (3.36) | (4.31) | (4.01) | (3.45) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.39 | 0.41 | 0.44 | 0.50 | 0.54 | 0.55 | 0.56 | 0.60 | 0.64 | 0.68 |
Operating CF/Net income |
1.56 | 1.53 | 1.73 | 1.60 | 1.79 | 1.45 | 1.45 | 1.35 | 1.54 | 1.86 |
Capex/Depreciation |
(0.65) | (0.67) | (1.08) | (0.28) | (0.24) | (0.16) | (0.12) | (0.33) | (0.35) | (0.25) |
| 13.93% | 13.63% | 12.58% | 14.72% | 16.51% | 19.33% | 20.74% | 21.44% | 19.40% | 13.40% | |
| 11.14% | 10.78% | 9.81% | 11.31% | 12.46% | 14.29% | 15.34% | 15.94% | 14.08% | 9.56% | |
ROIC |
87.58% | 63.35% | 43.49% | 46.76% | 58.99% | 39.18% | 30.90% | 94.38% | 68.41% | 56.38% |
Return on Tangible Assets |
14.13% | 14.38% | 13.54% | 16.19% | 18.41% | 23.05% | 29.10% | 21.14% | 19.93% | 15.06% |
Average Days of Receivables |
149.68 | 140.48 | 137.21 | 132.99 | 136.95 | 152.37 | 139.68 | 136.14 | 125.81 | 121.20 |
Research and Development Expense of Revenue |
24.02% | 25.23% | 26.61% | 24.14% | 20.64% | 20.08% | 19.01% | 18.42% | 19.12% | 17.57% |
Selling, General and Administrative Expense of Revenue |
22.83% | 24.12% | 26.57% | 26.28% | 24.83% | 26.22% | 27.59% | 27.29% | 27.40% | 28.96% |
Intangible Assets out of Total Assets |
0.05 | 0.07 | 0.09 | 0.11 | 0.14 | 0.18 | 0.25 | 0.07 | 0.10 | 0.15 |
Share Based Compensation of Revenue |
14.79% | 15.92% | 16.66% | 16.33% | 12.68% | 12.63% | 10.50% | 8.86% | 7.83% | 7.41% |
Graham Net Nets |
0.19 | 0.13 | 0.11 | 0.11 | 0.06 | 0.04 | 0.04 | 0.06 | 0.08 | 0.08 |
Graham Number |
74.26 | 59.79 | 46.21 | 41.04 | 34.54 | 29.20 | 22.74 | 17.52 | 12.12 | 7.87 |
Earnings Yield |
2.73% | 1.89% | 1.58% | 1.84% | 1.18% | 0.89% | 1.39% | 1.46% | 1.61% | 1.35% |
Free Cash Flow Yield |
4.16% | 2.83% | 2.66% | 2.89% | 2.07% | 1.27% | 2.00% | 1.91% | 2.52% | 2.38% |
Revenue per Share |
19.52 | 16.97 | 14.72 | 13.87 | 12.08 | 9.72 | 7.47 | 5.98 | 4.92 | 4.06 |
Operating CF per Share |
8.65 | 6.73 | 5.68 | 5.02 | 4.99 | 3.66 | 2.96 | 2.15 | 1.66 | 1.06 |
Capex per Share |
(0.18) | (0.13) | (0.16) | (0.09) | (0.09) | (0.06) | (0.03) | (0.07) | (0.08) | (0.06) |
Free Cash Flow per Share |
8.47 | 6.61 | 5.51 | 4.94 | 4.90 | 3.60 | 2.93 | 2.09 | 1.58 | 1.01 |
Cash per Share |
40.09 | 31.82 | 25.09 | 19.97 | 15.50 | 11.04 | 7.35 | 7.56 | 5.43 | 3.82 |
Shareholders Equity per Share |
44.08 | 36.03 | 28.93 | 23.92 | 19.00 | 15.04 | 11.27 | 8.58 | 6.46 | 4.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
44.08 | 36.03 | 28.93 | 23.92 | 19.00 | 15.04 | 11.27 | 8.58 | 6.46 | 4.81 |
Free Cash Flow |
1,386.09 | 1,069.53 | 885.14 | 766.96 | 750.25 | 542.56 | 433.05 | 301.01 | 222.07 | 136.50 |
Working Capital |
6,360.57 | 4,910.40 | 3,824.33 | 2,962.51 | 2,266.40 | 1,594.87 | 979.95 | 1,032.39 | 706.25 | 465.08 |
Capital Expenditures |
(29.13) | (20.52) | (26.20) | (13.51) | (14.21) | (8.68) | (4.32) | (9.82) | (11.37) | (7.51) |
Net Current Asset Value |
6,233.04 | 4,801.42 | 3,737.12 | 2,881.27 | 2,202.36 | 1,531.08 | 924.94 | 1,017.40 | 688.33 | 447.14 |
EV/EBIT |
29.16 | 47.16 | 68.17 | 50.97 | 67.01 | 108.42 | 71.91 | 65.69 | 51.02 | 43.30 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.01 |
Price to Operating Income |
36.32 | 54.61 | 77.55 | 57.72 | 71.71 | 112.83 | 75.71 | 70.59 | 55.85 | 47.59 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.64 | 0.54 | 0.42 | 0.96 | 1.10 | 0.99 | 0.68 | 0.55 | 0.62 | 0.60 |
Cash ROIC |
10.06% | 9.74% | 10.21% | 11.25% | 14.19% | 13.81% | 15.73% | 12.93% | 13.31% | 11.65% |
Accounts Receivable Turnover |
2.70 | 2.82 | 2.82 | 2.91 | 2.83 | 2.83 | 2.97 | 3.08 | 3.28 | 3.36 |
Accounts Payable Turnover |
22.97 | 22.58 | 18.51 | 19.65 | 23.10 | 19.17 | 21.27 | 30.56 | 33.50 | 33.80 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
17.57 | 15.88 | 16.98 | 24.96 | 14.75 | 20.76 | 23.37 | 13.56 | 11.99 | 11.93 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1,183.73 | 972.83 | 836.88 | 739.81 | 653.00 | 517.05 | 372.05 | 279.80 | 210.42 | 163.81 |
Average Payables |
34.05 | 30.98 | 36.60 | 31.01 | 21.80 | 21.34 | 14.27 | 8.03 | 6.31 | 5.14 |
Average Assets |
8,159.55 | 6,625.34 | 5,357.61 | 4,310.38 | 3,431.27 | 2,658.92 | 1,962.77 | 1,442.05 | 1,073.85 | 811.59 |
Average Common Equity |
6,523.56 | 5,238.60 | 4,180.54 | 3,313.94 | 2,588.98 | 1,965.96 | 1,451.67 | 1,071.99 | 779.45 | 578.95 |
Columns are period end dates · fundamentals updated 25 Oct 2026